^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

MSC2504877

i
Other names: MSC2504877
News
Trials
Company:
EMD Serono, Institute of Cancer Research
Drug class:
TNKS inhibitor
News
Trials